Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SITAGLIPTIN PHOSPHATE
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fed Conditions.
- Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.
- Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects
- Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
- Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
- Treatment of Diabetes After Gastric Bypass With Sitagliptin
- A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)
- Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
- Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
- Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
- A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
- A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)
- A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)
- Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)
- A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)
- Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)
- Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism
- ALPHA Sitagliptin Add on to Metformin (0431-103)
- Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
- A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)
- Incretin Effect in People With Impaired Fasting Glucose
- Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
- A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
- A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)
- An Open-Label, Single- & Multiple-Dose Study to Investigate the Pharmacokinetics of Sitagliptin 100 mg in Healthy Chinese Adult Subjects (0431-108)(COMPLETED)
- Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)
- Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)
- Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin
- Sitagliptin Treatment in Patients With Type 2 DM After Kidney Transplant
- Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
- A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)
- A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
- Sitagliptin Added-on to Insulin Study (0431-051)
- MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
- Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
- MK0431 Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-040)
- A Study of an Investigational Drug Sitagliptin for Type 2 Diabetes Mellitus (0431-044)
- Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)
Clinical trials list
click for details